Zhao Laboratory
Di Zhao, Ph.D.
Principal Investigator
Areas of Research
- Prostate Cancer Research
- Targeted Therapy Research
Dr. Zhao’s laboratory in the Experimental Radiation Oncology (ERO) department is interested in the functional genomics of prostate cancers with two primary directives: (1) understanding how oncogenic signaling pathways and tumor microenvironment regulate cancer development and metastasis, and (2) searching for biomarkers and context-specific therapeutic targets for personalized cancer medicine.
Recent Publications
Li H, Wang Y, Lin K, Venkadakrishnan VB, Bakht M, Shi W, Meng C, Zhang J, Tremble K, Liang X, Song JH, Feng X, Van V, Deng P, Burks JK, Aparicio A, Keyomarsi K, Chen J, Lu Y, Beltran H, Zhao D. CHD1 promotes sensitivity to Aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2. Cancer Res. 2022 Jun 30:can.22.0631. doi: 10.1158/0008-5472.CAN-22-0631. Epub ahead of print. PMID: 35771632.
Our Funding
NIH/NCI Pathway to Independence Award (K99/R00)
9/14/2018-8/31/2023
Principal Investigator
CPRIT Recruitment of First-Time Tenure-Track Faculty Award
6/1/2019-5/31/2024
Principal Investigator
Prostate Cancer Foundation Young Investigator Award
7/10/2017-6/31/2021
Principal Investigator
The University of Texas UT System Rising STARs Award
9/1/2019-8/31/2021
Principal Investigator
The University of Texas MD Anderson Cancer Center Prostate Cancer SPORE CEP Award
9/1/2020-8/31/2021
Principal Investigator
Contact Information
Lab location:
Zayed Building Z7.4018
6565 MD Anderson Blvd Unit 1052
Houston, TX 77030
Contact Dr. Zhao:
P: 713-792-7328 | Office: Z7.3028
Email: Dzhao2@mdanderson.org